According to Aclaris Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.67. At the end of 2024 the company had a P/S ratio of 3.08.
Year | P/S ratio | Change |
---|---|---|
2024 | 3.08 | 29.51% |
2023 | 2.38 | -93.26% |
2022 | 35.3 | -73.19% |
2021 | 132 | 192.45% |
2020 | 45.0 | 142.74% |
2019 | 18.5 | -41.64% |
2018 | 31.8 | -92.96% |
2017 | 452 | |
2016 | N/A | |
2015 | N/A |